After all, the biotech's valuation is still fairly attractive, as its shares trade at less than 5x projected sales. All things considered, Acadia's shares ought to perform reasonably well over the ...

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...

Like other mature drug manufacturers, Eli Lilly and Company (NYSE: LLY) is banking on innovative biotechnology platforms ... The only thing hotter than Lilly’s share price is its valuation.

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...

In particular, there are three things to pay attention to that'll give ... For a pre-product biotech, the best SABs are staffed with the leading researchers in the field of science that's the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Where are the stock market leaders? I asked this all-important question in a recent RiskHedge Report… and the answer I found was not good. A healthy market needs at least one strong sector to ...

By the late 19th century, as the cosmetics industry was scaling up, carmine was a natural choice of ingredient for red, pink, and peach products. Right now, making the biotech version costs more ...

The eye-catching red lipstick ... from sugar and other renewable sources. Biotech ingredients are nature-identical, genetic duplicates of the real thing. Take Naringenin, a skincare ingredient ...